Covid-19: More than 4 out of 10 French people have received their booster dose


Vaccination against Covid-19 is still progressing in France. According to data from Public Health France, 44% of French people have already received their booster dose.

This is the government’s strategy. Vaccinate as many French people as possible with a booster dose to limit hospitalizations linked to the Omicron variant of Covid-19 which is sweeping Europe and the whole world. As of January 11, 2022, the estimate of vaccination coverage in the general population from the Covid vaccine was 77.6% for a complete primary vaccination and 44.0% for the booster dose, explains Public Health France in its weekly report. Among those aged 18 and over, 55.7% had received a booster dose and 66.8% of those who were eligible for the booster on that date had actually received it. Among those aged 65 and over, 76.4% had received a booster dose and 85.5% of those who were eligible on that date had received it. In addition, 4.2% of children aged 10 to 11 received a first dose of vaccine (1.3% for 5 to 9 year olds).

Lower hospital indicators

Under the pressure of the now largely majority Omicron variant (89% of cases), the circulation of Covid-19 has increased sharply in France, with an incidence rate of more than 2,000 cases per 100,000 inhabitants in all metropolitan regions. and overseas. The increase in the number of hospitalizations and admissions to critical care significantly increases the pressure on hospital care, warns SPF, but the increase in hospital admissions is less marked during this wave, compared to the increase in the incidence. “Several factors contribute to the low proportion of cases admitted to hospital: a lower severity of infection with the Omicron variant, as indicated by the investigations of the first cases detected in France and international data; the progress of the recall campaign which contributed to the reduction in the occurrence of serious cases; finally, the greater circulation of the virus among the youngest, less at risk of a serious form”, further details Public Health France. The incidence rate is thus highest among 20-29 year olds (+44%) and among 10-19 year olds (+104%).

Any reproduction prohibited



Source link -112

Leave a Reply